Complementarity-determining region (CDR) implantation: A theme of recombination

Immunotechnology

Volumn 4, Issue 3-4, 1999, Pages 279-285

  Söderlind, Eskil ^a   Ohlin, Mats ^b   Carlsson, Roland ^a  

^a BioInvent International AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Antibody engineering; CDR implantation; Complementarity determining region; Genetic variation

Indexed keywords

ANTIBODY PRODUCTION; COMPLEMENTARITY DETERMINING REGION; DNA SEQUENCE; GENE LIBRARY; GENETIC ENGINEERING; GENETIC RECOMBINATION; GENETIC VARIABILITY; PRIORITY JOURNAL; REVIEW;

EID: 0033103199     PISSN: 13802933     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1380-2933(98)00027-X     Document Type: Note

References (25)

1. Smith GP. Science 1985;228:1315-7.
2. Parmley SF, Smith GP. Gene 1988;73:305-18.
3. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Nature 1990;348:552-4.
4. Barbas, III CF, Kang AS, Lerner RA, Benkovic SJ. Proc Natl Acad Sci USA 1991;88:7978-82.
5. Söderlind E, Lagerkvist AC, Duenas M, Malmborg AC, Ayala M, Danielsson L, Borrebaeck CAK. Biotechnology 1993;11:503-7.
6. Barbas, III CF, Bain JD, Hoekstra DM, Lerner RA. Proc Natl Acad Sci USA 1992;89:4457-61.
7. Hoogenboom HR, Winter G. J Mol Biol 1992;227:381-8.
8. Garrard LJ, Henner DJ. Gene 1993;128:103-9.
9. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM, Allison TJ, et al. EMBO J 1994;13:3245-60.
10. Jirholt P, Ohlin M, Borrebaeck CAK, Söderlind E. Gene 1998;215:471-6.
11. Goossens T, Klein U, Küppers R. Proc Natl Acad Sci USA 1998;95:2463-8.
12. Ohlin M, Borrebaeck CAK. Mol Immunol 1998;35:233-8.
13. Wilson PC, de Bouteiller O, Liu YJ, Potter K, Banchereau J, Capra JD, Pascual V. J Exp Med 1998;187:59-70.
14. Huse WD, Sastry L, Iverson SA, Kang AS, Alting-Mees M, Burton DR, Benkovic SJ, Lerner RA. Science 1989;246:1275-81.
15. Clackson T, Hoogenboom HR, Griffiths AD, Winter G. Nature 1991;352:624-8.
16. Söderlind E, Vergeles M, Borrebaeck CAK. Gene 1995;160:269-72.
17. Kobayashi N, Söderlind E, Borrebaeck CAK. Biotechniques 1997;23:500-3.
18. Huse WD, Yelton DE, Glaser SM. Int Rev Immunol 1993;10:129-37.
19. Virnekäs B, Ge L, Pluckthun A, Schneider KC, Wellnhofer G, Moroney SE. Nucleic Acids Res 1994;22:5600-7.
20. Crameri A, Raillard SA, Bermudez E, Stemmer WP. Nature 1998;391:288-91.
21. Chothia C, Lesk AM, Gherardi E, Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G. J Mol Biol 1992;227:799-817.
22. Lara-Ochoa F, Almagro JC, Vargas-Madrazo E, Conrad M. J Mol Evol 1996;43:678-84.
23. Ohlin M, Jirholt P, Thorsteinsdottir HB, Söderlind E, Borrebaeck CAK. In: Antibody Engineering - New Technology, Application and Commercialisation. London: IBC Business Publishing (in press).
24. Barbas CF, Hu D, Dunlop N, Sawyer L, Cababa D, Hendry RM, Nara PL, Burton DR. Proc Natl Acad Sci USA 1994;91:3809-13.
25. Tomlinson IM. VBASE. The Database of Human Anti-body Genes. URL:http://www.mrc-cpe.cam.ac.uk/imt-doc/public/INTRO.html